Quick Answer
LifeStance Health Group, Inc. reported Operating Income Loss of $24.15 million for the year ending 2025.
- LifeStance Health Group, Inc. showed an increase of +176.4% in Operating Income Loss from 2024 to 2025.
- This data is from LifeStance Health Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $8.70 million | Q2 2020: $3.06 million | Q2 2020: $104.0 thousand | Q3 2020: $2.69 million | Q1 2021: -$881.0 thousand | Q2 2021: -$47.05 million | Q3 2021: -$124.67 million | Q1 2022: -$64.85 million | Q2 2022: -$60.47 million | Q3 2022: -$38.84 million | Q1 2023: -$34.09 million | Q2 2023: -$48.41 million | Q3 2023: -$74.36 million | Q1 2024: -$16.77 million | Q2 2024: -$15.95 million | Q3 2024: $47.0 thousand | Q1 2025: $1.60 million | Q2 2025: -$2.95 million | Q3 2025: $7.41 million.
- Over the full 6 years of available data (2019 to 2025), LifeStance Health Group, Inc.'s Operating Income Loss has grown by 58.4%.
- Historical annual values: Fiscal year 2025: $24.15 million | Fiscal year 2024: -$31.61 million | Fiscal year 2023: -$189.13 million | Fiscal year 2022: -$210.17 million | Fiscal year 2021: -$286.35 million | Fiscal year 2019: $15.24 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: